Biomaterials Market by Type (Ceramics, Metallic Biomaterials, Natural Biomaterials), Classification (Bioactive Biomaterials, Bioinert Biomaterials, Bioresorbable Biomaterials), Application - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the biomaterials market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[192 Pages Report] The Biomaterials Market size was estimated at USD 167.28 billion in 2023 and expected to reach USD 193.38 billion in 2024, at a CAGR 15.69% to reach USD 464.18 billion by 2030.

Biomaterials Market
To learn more about this report, request a free PDF copy

The biomaterials market includes developing, producing, and marketing natural or synthetic materials that interact with biological systems for medical reasons, such as diagnostic, therapeutic, or replacement operations. An aging global population and the resulting increase in occurrences of chronic and lifestyle diseases are major demand drivers for the market. The rise in the adoption of medical implants and an upswing in the number of cosmetic and plastic surgeries also contribute to market growth. Technological advancements for the development of more sophisticated and improved biomaterials are further stimulating market expansion. Moreover, increased healthcare expenditure and advancements in nanotechnology and regenerative medicine are buoying the biomaterials market. However, strict regulatory requirements for the approval of new biomaterials can lead to lengthy and expensive approval processes, limiting the market growth. Biocompatibility issues and incidences of adverse reactions within the body may also challenge the market growth. Moreover, the development of smart biomaterials that can respond to biological stimuli and the integration of biomaterials with living cells and tissues to produce more complex tissue constructs are expected to create new opportunities for market growth. Innovations in 3D printing technologies and the growing field of personalized medicine are also anticipated to present significant opportunities for business growth.

Biomaterials Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Type:Advancements in Natural biomaterials for improved functionality

Ceramics are favored for their biocompatibility, exceptional strength, and hardness, as they are commonly used in orthopedic and dental applications. Ceramics include bioinert materials such as zirconia and bioactive materials such as hydroxyapatite. The preference for ceramics is often due to their stability and durability in load-bearing applications. Metallic biomaterials stand out for their high mechanical strength and are predominantly used in orthopedic and cardiovascular applications. Natural biomaterials are derived from living organisms and are selected for their excellent biocompatibility and functionality. Natural biomaterials, including collagen, chitin, alginate, and silk, are extensively used in tissue engineering and wound healing applications. Polymeric biomaterials, including natural and synthetic polymers, are versatile materials used in various medical devices and implants.

Application: Diverse applications of biomaterials across industries

In cardiovascular applications, biomaterials primarily focus on constructing blood vessel prostheses, heart valves, and stents. The need arises from the increasing prevalence of cardiovascular diseases (CVDs) globally, driving demand for durable and biocompatible materials. The dental segment utilizes biomaterials for fillings, implants, and reconstructive surgery. The growing emphasis on aesthetic dentistry and the increasing incidence of dental diseases drive the demand for biomaterials. Biomaterials for the nervous system are utilized in treatments for neural injuries, brain tumors, and neurodegenerative diseases. The demand for biomaterials is propelled by the complexity of neural tissues and the need for materials that mimic or support neural function. In ophthalmology, biomaterials find applications in contact lenses, intraocular lenses (IOLs), and corneal implants, driven by the rising prevalence of visual impairments and a desire for minimally invasive solutions. Orthopedic applications of biomaterials include joint replacements, bone grafts, and scaffolds for bone regeneration, targeting the increasing incidence of musculoskeletal conditions and sports injuries. Biomaterials in plastic surgery are used for soft tissue fillers, implants, and reconstructive scaffolds. Tissue engineering applications harness biomaterials to develop artificial organs and regenerative solutions. Biomaterials in wound healing are applied in dressings, sutures, and skin grafts. The need stems from the quest for faster healing, reduced infection rates, and improved outcomes in chronic wound management.

Regional Insights

The Americas region, primarily the United States and Canada, demonstrates a substantial interest in synthetic biomaterials in high-end medical devices and implants. The U.S. market is driven by innovative product development and extensive research funding, including significant investments in 3D printing technologies for medical applications. Canada showcases a growing interest in biopolymers, supported by government initiatives towards sustainable healthcare solutions. Europe, the Middle East, and Africa (EMEA) exhibit diverse customer needs influenced by regulatory, economic, and demographic factors. European countries stand out for their stringent regulatory frameworks favoring high-quality standards and sustainability in biomaterials, with notable research in nanotechnology and bioresorbable materials. The Middle East, with its rapidly developing healthcare infrastructure, presents opportunities for advanced medical devices and implants. Africa, although in the early stages of market development, shows potential for natural and sustainable biomaterials driven by increasing healthcare investments and awareness. The Asia Pacific region, consisting of China, Japan, India, and other countries, is witnessing a surge in demand for biomaterials due to a growing aging population and increased healthcare infrastructure investments. China, leading in both market size and growth, is a hub for innovation, evident from its series of new patents in biodegradable materials and regenerative products. Japan focuses on advanced research in polymers and composites for healthcare applications. India, with a robust growth in pharmaceutical and healthcare sectors, shows a high demand for natural biomaterials.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biomaterials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomaterials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Biomaterials Leader MycoWorks Announces Successful Harvest of First 1000 Sheets of Fine Mycelium and First Commercial Shipments, Paving Way for Product Launches

    MycoWorks, a key innovator in biotechnology, has made significant strides in the production of its luxury leather alternative, Fine Mycelium. The company's commercial-scale plant in South Carolina has outperformed its California pilot plant by harvesting over a thousand high-quality sheets of Fine Mycelium months ahead of schedule, with the facility set to increase production further, due to the pre-reservation of nearly two years' capacity by clients and partners. [Published On: 2024-01-08]

  • IFF Launches Designed Enzymatic Biomaterials Technology Platform

    IFF has announced the launch of its groundbreaking Designed Enzymatic Biomaterials (DEB) technology, which revolutionizes the development of eco-friendly, high-performance biopolymers. DEB technology marks a significant advancement by enabling the creation of biopolymer materials with the functionalities of petroleum-based polymers, but without the environmental impact. IFF's DEB technology stands as a pivotal development toward sustainable alternatives in material science. [Published On: 2023-09-26]

  • Biomaterials Start-up altM Raises USD 3.5 Million in Seed Funding from Omnivore, others

    Bengaluru-based biomaterials startup altM has secured USD 3.5 million in seed funding from private investors to develop scalable biomaterials utilizing lignocellulosic agricultural residues. This endeavor aims to provide industrial sectors with sustainable alternatives to reduce carbon footprints effectively. AltM stands out as a pioneering initiative within the OmniX Bio program targeting early-stage agrifood life science companies. [Published On: 2023-09-07]

Key Company Profiles

The report delves into recent significant developments in the Biomaterials Market, highlighting leading vendors and their innovative profiles. These include Ametex Inc., BASF SE, Berkeley Advanced Biomaterials, Braskem, CAM Bioceramics B.V., CDI Products, Celanese Corporation, CeramTec GmbH, CoorsTek, Inc., Corbion NV, Covalon Technologies Ltd., Danimer Scientific, Dentsply Sirona Inc., Eastman Chemical Company, Evonik Industries AG, GELITA AG, Invibio Ltd. by Victrex PLC, Koninklijke DSM N.V., KURARAY Co., Ltd., Medical Device Business Services, Inc. by Johnson & Johnson Services, Inc., Medtronic Plc, Noble Biomaterials, Stryker Corporation, Tissium, and Toray Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Biomaterials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Ceramics
      • Aluminum Oxide
      • Calcium Phosphate
      • Calcium Sulfate
      • Carbon
      • Glass
      • Zirconia
    • Metallic Biomaterials
      • Cobalt-Chrome Alloys
      • Gold
      • Magnesium
      • Silver
      • Stainless Steel
      • Titanium & Titanium Alloys
    • Natural Biomaterials
      • Alginates
      • Cellulose
      • Chitin
      • Collagen
      • Fibrin
      • Gelatin
      • Hyaluronic Acid
      • Silk
    • Polymeric Biomaterials
      • Nylon
      • Polyester
      • Polyetheretherketone
      • Polyethylene
      • Polymethylmethacrylate
      • Polyvinylchloride
      • Silicone Rubber
  • Classification
    • Bioactive Biomaterials
    • Bioinert Biomaterials
    • Bioresorbable Biomaterials
  • Application
    • Cardiovascular
    • Dental
    • Neurological/Central Nervous System Applications
    • Ophthalmology
    • Orthopedic
    • Plastic Surgery
    • Tissue Engineering
    • Wound Healing

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Biomaterials Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomaterials Market?
  3. What are the technology trends and regulatory frameworks in the Biomaterials Market?
  4. What is the market share of the leading vendors in the Biomaterials Market?
  5. Which modes and strategic moves are suitable for entering the Biomaterials Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Biomaterials Market, by Type
  7. Biomaterials Market, by Classification
  8. Biomaterials Market, by Application
  9. Americas Biomaterials Market
  10. Asia-Pacific Biomaterials Market
  11. Europe, Middle East & Africa Biomaterials Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 688]
  16. List of Companies Mentioned [Total: 25]
Frequently Asked Questions
  1. How big is the Biomaterials Market?
    Ans. The Global Biomaterials Market size was estimated at USD 167.28 billion in 2023 and expected to reach USD 193.38 billion in 2024.
  2. What is the Biomaterials Market growth?
    Ans. The Global Biomaterials Market to grow USD 464.18 billion by 2030, at a CAGR of 15.69%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.